Product Information on Aminosyn 3.5% M In Plastic Container 3.5%;21MG/100ML;40MG/100ML;128MG/100ML;234MG/100ML

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Amino Acids; Magnesium Acetate; Phosphoric Acid; Potassium Acetate; Sodium Chloride
Multiple ingredients are in alphabetical order.

Strength - 3.5%;21MG/100ML;40MG/100ML;128MG/100ML;234MG/100ML
The potency of the active ingredient(s), Amino Acids; Magnesium Acetate; Phosphoric Acid; Potassium Acetate; Sodium Chloride. May repeat for multiple part products.

Applicant - ABBOTT
The firm name holding legal responsibility for Aminosyn 3.5% M In Plastic Container. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 018875
The FDA assigned number to Aminosyn 3.5% M In Plastic Container. Format is nnnnnn.

Product Number - 002
The FDA assigned number to identify Aminosyn 3.5% M In Plastic Container. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Aug 8, 1984
The date Aminosyn 3.5% M In Plastic Container was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Aminosyn 3.5% M In Plastic Container. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Aminosyn 3.5% M In Plastic Container is in. Format is RX, OTC, DISCN.

Applicant Full Name - Abbott Laboratories Pharmaceutical Products Div
The full name of the firm holding legal responsibility for the new application of Aminosyn 3.5% M In Plastic Container.

Aminosyn 3.5% M In Plastic Container

NewDrugInformation